CEACAM5 and neoplasm: Patients with elevated CEA/CA19-9 levels had a higher age (p = 0.026) and more advanced clinical N (p = 0.002) and tumor node metastasis (TNM) stages (p = 0.002), and no significant differences were observed in other characteristics between the groups.